Skip to main content
. 2020 May 24;20:362. doi: 10.1186/s12879-020-05004-8

Table 3.

Correlation between Xpert MTB/RIF semi-quantitative results and AFB smear microscopy results

Prediction of Xpert positive AFB Smear results Prediction of AFB smear positivity
Total samples Confirmed TB PPV (95% CI) Negative 1+ 2+ 3+ 4+ Total smear positive Sensitivity (95% CI) PPV (95% CI)
Xpert results Positive high 12 12 100% (75.8–100) 3 2 2 5 0 9 75.0% (46.8–91.1) 100% (70.1–100)
Positive medium 13 13 100% (77.2–100) 6 6 0 1 0 7 53.9% (29.1–76.8) 100% (64.6–100)
Positive low 23 21 91.3% (73.2–97.6) 21 2 0 0 0 2 9.5% (2.7–28.9) 100% (34.2–100)
Positive very low 17 16 94.1% (73.0–99.0) 15 2 0 0 0 2 12.5% (3.5–36.0) 100% (34.2–100)
Negative 722 27 NPV = 96.3% (94.6–97.4) 715* 1 a 2 #a 3 b 1 a 7 3.7% (0.7–18.3) 14.3% (2.6–51.3)
Total 787 89 95.4% (87.3–98.4) 760 13 4 9 1 27 23.6% (15.2–33.8) 77.8% (59.2–89.3)

Abbreviation: CI confidence interval; PPV Positive predictive value; NPV Negative predictive value. *, include 26 false negative Xpert results; #, include 1 false negative Xpert result (1 true positive AFB smear result); a, include 1 false positive AFB smear result; b, include 3 false positive AFB smear results

Xpert MTB/RIF semi-quantitative results defined by the manufacturer as follows: positive very low (cycle threshold, CT > 28), low (22 < CT≤ 28), medium (16 < CT≤ 22) or high (CT ≤ 16)

AFB smear microscopy results were graded according to American Thoracic Society scale: Negative, 0 AFB/300 fields; Positive 1+, 1–9 AFB/100 fields; Positive 2+, 1–9 AFB/10 fields; Positive 3+, 1–9 AFB/field; Positive 4+, > 9 AFB/field